CMS Entry id: 2710 | Channel: News landing page | Template: news/index

News

News

17 August 2017

Evolocumab Phase 3 Cognitive Function Study Results Published in the New England Journal of Medicine

Cambridge Cognition and Amgen announce that the New England Journal of Medicine (NEJM) published results from the evolocumab cognitive function trial, which was conducted in a subset of patients enrolled in the randomized, placebo-controlled evolocumab cardiovascular outcomes study.


10 July 2017

Cognition and Alzheimer’s Technology at AAIC 2017

Cambridge Cognition is attending the Alzheimer's Association International Conference in London.

Schedule a meeting with us

13 June 2017

CANTAB Research Grant 2017 – Results

The 2017 CANTAB Research Grant was once again overwhelmed with applications. All the research proposals received were such high quality it was another impossible task for our funding committee to review and narrow the proposals down. We received applications from across the globe from Hong Kong to Saint Lucia. But there could only be 3 awards.

7 June 2017

Speech recognition to improve clinical trial efficiency

Cambridge Cognition is pleased to announce its application of automatic speech recognition (“ASR”) technology to develop new products to enable scalable, language-based clinical assessment to reduce clinical trial variability and costs and increase overall clinical trial efficiency.

19 May 2017

Cambridge Cognition support the next tech masterminds

During a week focusing on employment skills, businesses were invited to Cambridge Regional College (CRC) to talk to students during its Computer Industry Week, running practical workshops on interview preparation and skills.

16 May 2017

Creator of CANTAB receives Gold Medal Award from The Society of Biological Psychiatry

Co-creator of CANTAB (Cambridge Neuropsychological Test Automated Battery) Professor Trevor Robbins is to receive the Gold Medal Award on May 19, 2017, at the 72nd Annual Meeting in San Diego, California. The award honours pioneering contributions in the field of biological psychiatry and significant and sustained work that extends knowledge in the field.

3 May 2017

Cambridge Cognition CSO named in Top 40 Healthcare Transformers

Company CSO honoured at this year's ceremony celebrating leading health-tech innovators.

rss-feed-icon
Share this